Combination 830-nm and 633-nm light-emitting diode phototherapy shows promise in the treatment of recalcitrant psoriasis: preliminary findings.

BACKGROUND AND OBJECTIVES Psoriasis is one of the major problems facing dermatologists worldwide. Planar arrays of light-emitting diodes (LEDs) have recently attracted attention in the treatment of difficult dermatological entities, 830 nm in near infrared (near-IR) and 633 nm in visible red. This study was designed to assess the efficacy of combination 830-nm and 633-nm LED phototherapy in the treatment of recalcitrant psoriasis. SUBJECTS AND METHODS Nine informed and consenting patients with psoriasis were enrolled in this preliminary study, (3 men, 6 women, mean age 34.3, skin types I to IV). All had chronic psoriasis, which in most cases had proved resistant to conventional treatments. They were treated sequentially with LED arrays delivering continuous-wave 830 nm (near-IR) and 633 nm (red) in two 20-min sessions over 4 or 5 weeks, with 48 h between sessions (830 nm, 60 J/cm(2); 633 nm, 126 J/cm(2)). RESULTS All patients completed their LED regimens (4 requiring 1 regimen, 5 requiring a second). Follow-up periods were from 3 to 8 months, except in two patients who were lost to follow-up. Clearance rates at the end of the follow-up period ranged from 60% to 100%. Satisfaction was universally very high. CONCLUSIONS The antiinflammatory effects of LED energy at 830 nm and 633 nm have been well documented, as has their use in wound healing. LED phototherapy is easy to apply, pain free and side-effect free, and is well tolerated by patients of all skin types. The promising results of this preliminary study warrant a proper controlled double-blind study with a larger patient population.

[1]  B. Gersh.  Risk of Myocardial Infarction in Patients With Psoriasis , 2007 .

[2]  Y. Abiko,et al.  Inhibition of Interleukin-1β Production and Gene Expression in Human Gingival Fibroblasts by Low-energy Laser Irradiation , 2001, Lasers in Medical Science.

[3]  Ki-Ho Park,et al.  A prospective, randomized, placebo-controlled, double-blinded, and split-face clinical study on LED phototherapy for skin rejuvenation: clinical, profilometric, histologic, ultrastructural, and biochemical evaluations and comparison of three different treatment settings. , 2007, Journal of photochemistry and photobiology. B, Biology.

[4]  B. Thiers.  Pathogenesis and clinical features of psoriasis , 2008 .

[5]  Seung Yoon Lee,et al.  Blue and red light combination LED phototherapy for acne vulgaris in patients with skin phototype IV , 2007, Lasers in surgery and medicine.

[6]  S. Feldman,et al.  Psoriasis assessment tools in clinical trials , 2005, Annals of the rheumatic diseases.

[7]  Shigeru Sato,et al.  Light-emitting diode phototherapy at 630 +/- 3 nm increases local levels of skin-homing T-cells in human subjects. , 2006, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[8]  L. van der Fits,et al.  Peptidoglycan and peptidoglycan‐specific Th1 cells in psoriatic skin lesions , 2006, The Journal of pathology.

[9]  A. Bowcock,et al.  Psoriasis pathophysiology: current concepts of pathogenesis , 2005, Annals of the rheumatic diseases.

[10]  R. Sayre,et al.  The increase in melanoma: are dietary furocoumarins responsible? , 2008, Medical hypotheses.

[11]  Alessandro L. B. Vieira,et al.  Assessment of anti-inflammatory effect of 830nm laser light using C-reactive protein levels. , 2001, Brazilian dental journal.

[12]  J. Kubota,et al.  Effects of Diode Laser Therapy on Blood Flow in Axial Pattern Flaps in the Rat Model , 2002, Lasers in Medical Science.

[13]  H. Iwasaka,et al.  GaAlAs (830 nm) low‐level laser enhances peripheral endogenous opioid analgesia in rats , 2007, Lasers in surgery and medicine.

[14]  D. Goldberg,et al.  Combination blue (415 nm) and red (633 nm) LED phototherapy in the treatment of mild to severe acne vulgaris , 2006, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.